Transcriptional regulation of glucose sensors in pancreatic β cells and liver

Current Diabetes Reviews

Volumn 2, Issue 1, 2006, Pages 11-18

  Im, Seung Soon ^a,b,c   Kim, So Youn ^a,c   Kim, Ha Il ^a,c   Ahn, Yong Ho ^a,b,c  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Center for Chronic Metabolic Disease Research   (South Korea)

Author keywords

Glucokinase (GK); Glucose sensor; Liver; Pancreatic cells; Transcription; Type 2 glucose transporter isoform (GLUT2)

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; STREPTOZOCIN; TROGLITAZONE;

CELL ACTIVATION; CELL FUNCTION; CELL STIMULATION; CHROMOSOMAL LOCALIZATION; DIABETOGENESIS; DRUG MECHANISM; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC CODE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; INSULIN RESISTANCE; INSULIN SYNTHESIS; LIVER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STREPTOZOCIN DIABETES; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; DIABETES MELLITUS, TYPE 2; GLUCOKINASE; GLUCOSE TRANSPORTER TYPE 2; HUMANS; INSULIN; INSULIN-SECRETING CELLS; LIVER; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 33746163080     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339906775473581     Document Type: Review

References (92)

1. Porte D, Jr. Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 1991; 40:166-80.
2. Kahn CR. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994; 43: 1066-84.
3. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995; 75:473-86.
4. Saltiel AR. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 2001; 104:517-29.
5. Ader M, Ni TC and Bergman RN. Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components. J Clin Invest 1997; 99: 1187-99.
6. Matschinsky FM MM. Molecular pathogenesis of MODYs, In Frontiers in Diabetes. 2000; 15:
7. Mantovani V, Salardi S, Cerreta V, et al. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young. Hum Mutat 2003; 22:338.
8. Moller AM, Jensen NM, Pildal J, et al. Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2001; 86:2181-6.
9. Mueckler M, Kruse M, Strube M, et al. A mutation in the Glut2 glucose transporter gene of a diabetic patient abolishes transport activity. J Biol Chem 1994; 269:17765-7.
10. Iynedjian PB, Pilot PR, Nouspikel T, et al. Differential expression and regulation of the glucokinase gene in liver and islets of Langerhans. Proc Natl Acad Sci U S A 1989; 86:7838-42.
11. Liang Y, Najafi H, Smith RM, et al. Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture. Diabetes 1992; 41:792-806.
12. Fernandez-Mejia C, Vega-Allende J, Rojas-Ochoa A, et al. Cyclic adenosine 3′,5′-monophosphate increases pancreatic glucokinase activity and gene expression. Endocrinology 2001; 142:1448-52.
13. Hayzer DJ and Iynedjian PB. Alternative splicing of glucokinase mRNA in rat liver. Biochem J 1990; 270:261-3.
14. Fukumoto H, Seino S, Imura H, et al. Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc Natl Acad Sci U S A 1988; 85:5434-8.
15. Ahn YH, Kim JW, Han GS, ef al. Cloning and characterization of rat pancreatic beta-cell/liver type glucose transporter gene: a unique exon/ intron organization. Arch Biochem Biophys 1995; 323: 387-96.
16. Matsutani A, Janssen R, Donis-Keller H, et al. A polymorphic (CA)n repeat element maps the human glucokinase gene (GCK) to chromosome 7p. Genomics 1992; 12:319-25.
17. Andreone TL, Printz RL, Pilkis SJ, et al. The amino acid sequence of rat liver glucokinase deduced from cloned cDNA. J Biol Chem 1989; 264:363-9.
18. Magnuson MA. Glucokinase gene structure. Functional implications of molecular genetic studies. Diabetes 1990; 39: 523-7.
19. Kahn SE. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001; 86:4047-58.
20. Johnson JH, Ogawa A, Chen L, et al. Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes. Science 1990; 250:546-9.
21. Matschinsky F, Magnuson, MA. Molecular pathogenesis of MODYs, In Frontiers in Diabetes. 2000; 15
22. Thorens B, Guillam MT, Beermann F, et al. Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion. J Biol Chem 2000; 275:23751-8.
23. Postic C, Shiota M, Niswender KD, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999; 274:305-15.
24. Decaux JF, Antoine B and Kahn A. Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture. J Biol Chem 1989; 264:11584-90.
25. Goto Y and Mariash CN. Cell-specific carbohydrate metabolism regulates S14 gene transcription. Diabetes 1992; 41:339-46.
26. Prip-Buus C, Perdereau D, Foufelle F, et al. Induction of fatty-acid-synthase gene expression by glucose in primary culture of rat hepatocytes. Dependency upon glucokinase activity. Eur J Biochem 1995; 230:309-15.
27. Girard J, Ferre P and Foufelle F. Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Annu Rev Nutr 1997; 17:325-52.
28. Ferre T, Riu E, Bosch F, el al. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. Faseb J 1996; 10:1213-8.
29. Hariharan N, Farrelly D, Hagan D, et al. Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight. Diabetes 1997; 46:11-6.
30. Niswender KD, Shiota M, Postic C, et al. Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem 1997; 272:22570-5.
31. Burcelin R, del Carmen Munoz M, Guillam MT, et al. Liver hyperplasia and paradoxical regulation of glycogen metabolism and glucose-sensitive gene expression in GLUT2-null hepatocytes. Further evidence for the existence of a membrane-based glucose release pathway. J Biol Chem 2000; 275:10930-6.
32. Cha JY, Kim H, Kim KS, et al. Identification of transsacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene. Cooperative role of hepatocyte nuclear factors 1alpha and 3beta. J Biol Chem 2000; 275:18358-65.
33. Stoffel M and Duncan SA. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sci USA 1997; 94:13209-14.
34. Kim JW and Ahn YH. CCAAT/enhancer binding protein regulates the promoter activity of the rat GLUT2 glucose transporter gene in liver cells. Biochem J 1998; 336 (Pt 1):83-90.
35. Im SS, Kim JW, Kim TH, et al. Identification and characterization of peroxisome proliferator response element in the mouse GLUT2 promoter. Exp Mol Med 2005; 37:101-10.
36. Kim HI, Kim JW, Kim SH, et al. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes 2000; 49:1517-24.
37. Rahimian R, Masih-Khan E, Lo M, et al. Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol Cell Biochem 2001; 224:29-37.
38. Ohlsson H, Karlsson K and Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J 1993; 12: 4251-9.
39. Waeber G, Thompson N, Nicod P, et al. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol Endocrinol 1996; 10:1327-34.
40. Chakrabarti SK, James JC and Mirmira RG. Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J Biol Chem 2002; 277:13286-93.
41. Parrizas M, Maestro MA, Boj SF, et al. Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol Cell Biol 2001; 21:3234-43.
42. Yamagata K, Nammo T, Moriwaki M, et al. Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes. Diabetes 2002; 51:114-23.
43. Lee CS, Sund NJ, Vatamaniuk MZ, et al. Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo. Diabetes 2002; 51: 2546-51.
44. Shen W, Scearce LM, Brestelli JE, et al. Foxa3 (hepatocyte nuclear factor 3gamma) is required for the regulation of hepatic GLUT2 expression and the maintenance of glucose homeostasis during a prolonged fast. J Biol Chem 2001; 276: 42812-7.
45. Gannon M, Ray MK, Van Zee Y., et al. Persistent expression of HNF6 in islet endocrine cells causes disrupted islet architecture and loss of beta cell function. Development 2000; 127:2883-95.
46. Rencurel F, Waeber G, Bonny C, et al. cAMP prevents the glucose-mediated stimulation of GLUT2 gene transcription in hepatocytes. Biochem J 1997; 322 (Pt 2):441-8.
47. Berkowitz K, Peters R, Kjos SL, et al. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM. Diabetes 1996; 45:1572-9.
48. Brown KK, Henke BR, Blanchard SG, et al. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes 1999; 48:1415-24.
49. Higa M, Zhou YT, Ravazzola M, et al. Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci USA 1999; 96:11513-8.
50. Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003; 423:550-5.
51. Im SS, Kang SY, Kim SY, et al. Glucose-Stimulated Upregulation of GLUT2 Gene Is Mediated by Sterol Response Element-Binding Protein-1c in the Hepatocytes. Diabetes 2005; 54:1684-91.
52. Postic C, Burcelin R, Rencurel F, et al. Evidence for a transient inhibitory effect of insulin on GLUT2 expression in the liver: studies in vivo and in vitro. Biochem J 1993; 293 (Pt 1):119-24.
53. Jetton TL, Liang Y, Pettepher CC, et al. Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J Biol Chem 1994; 269:3641-54.
54. Shelton KD, Franklin AJ, Khoor A, et al. Multiple elements in the upstream glucokinase promoter contribute to transcription in insulinoma cells. Mol Cell Biol 1992; 12:4578-89.
55. Moates JM, Shelton KD and Magnuson MA. Characterization of the Pal motifs in the upstream glucokinase promoter: binding of a cell type-specific protein complex correlates with transcriptional activation. Mol Endocrinol 1996; 10:723-31.
56. Jonsson J, Carlsson L, Edlund T, et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994; 371:606-9.
57. Leibiger IB, Walther R, Pett U, et al. Positive and negative regulatory elements are involved in transcriptional control of the rat glucokinase gene in the insulin producing cell line HIT M2.2.2. FEBS Lett 1994; 337:161-6.
58. Watada H, Kajimoto Y, Umayahara Y, et al. The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/ PDX-1 in its activation in HIT-T15 cells. Diabetes 1996; 45:1478-88.
59. Patane G, Kaneto H, Toschi E, et al. Induction of Mad expression leads to augmentation of insulin gene transcription. Biochem Biophys Res Commun 2003; 303:1199-208.
60. Ben-Shushan E, Marshak S, Shoshkes M, et al. A pancreatic beta - cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta), HNF-1alpha, and SPs transcription factors. J Biol Chem 2001; 276:17533-40.
61. Shih DQ, Screenan S, Munoz KN, et al. Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 2001; 50: 2472-80.
62. Wang H, Gauthier BR, Hagenfeldt-Johansson KA, et al. Foxa2 (HNF3beta) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release. J Biol Chem 2002; 277:17564-70.
63. Ahlgren U, Jonsson J, Jonsson L, et al. beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 1998; 12: 1763-8.
64. Moates JM, Nanda S, Cissell MA, et al. BETA2 activates transcription from the upstream glucokinase gene promoter in islet beta-cells and gut endocrine cells. Diabetes 2003; 52:403-8.
65. Kim JY, Chu K, Kim HJ, et al. Orphan Nuclear Receptor Small Heterodimer Partner, a Novel Corepressor for a Basic Helix-Loop-Helix Transcription Factor BETA2/NeuroD. Mol Endocrinol 2004; 18: 776-90.
66. Wang MY, Koyama K, Shimabukuro M, et al. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. Proc Natl Acad Sci USA 1998; 95:11921-6.
67. Kim HI, Cha JY, Kim SY, et al. Peroxisomal proliferator-activated receptor-gamma upregulates glucokinase gene expression in beta-cells. Diabetes 2002; 51:676-85.
68. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995; 44: 863-70.
69. Cabrera-Valladares G, German MS, Matschinsky FM, et al. Effect of retinoic acid on glucokinase activity and gene expression and on insulin secretion in primary cultures of pancreatic islets. Endocrinology 1999; 140:3091-6.
70. Le Lay J, Matsuoka TA, Henderson E, et al. Identification of a novel PDX-1 binding site in the human insulin gene enhancer. J Biol Chem 2004; 279:22228-35.
71. Kim JB, Wright HM, Wright M, et al. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci USA 1998; 95:4333-7.
72. Fajas L, Schoonjans K, Gelman L, et al. Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol Cell Biol 1999; 19:5495-503.
73. Diraison F, Parton L, Ferre P, et al. Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem J 2004; 378:769-78.
74. Leibiger B, Leibiger IB, Moede T, et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol Cell 2001; 7: 559-70.
75. Leibiger B, Leibiger IB, Moede T, et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol Cell 2001; 7: 559-70.
76. Iynedjian PB, Gjinovci A and Renold AE. Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats. J Biol Chem 1988; 263:740-4.
77. Michael MD, Kulkarni RN, Postic C, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000; 6:87-97.
78. Iynedjian PB, Jotterand D, Nouspikel T, et al. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system. J Biol Chem 1989; 264: 21824-9.
79. Magnuson MA and Shelton KD. An alternate promoter in the glucokinase gene is active in the pancreatic beta cell. J Biol Chem 1989; 264:15936-42.
80. Horton JD, Bashmakov Y, Shimomura I, et al. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci USA 1998; 95:5987-92.
81. Kim JB, Sarraf P, Wright M, et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest 1998; 101:1-9.
82. Foretz M, Pacot C. Dugail I, et al. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 1999; 19:3760-8.
83. Shimomura I, Bashmakov Y, Ikemoto S, et al. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1999; 96: 13656-61.
84. Becard D, Hainault I, Azzout-Marniche D, et al. Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 2001; 50:2425-30.
85. Foretz M, Guichard C, Ferre P, et al. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 1999; 96:12737-42.
86. Kim SY, Kim HI, Kim TH, et al. SREBP-1c mediates the insulin-dependent hepatic glucokinase expression. J Biol Chem 2004; 279: 30823-9.
87. Roth U, Curth K, Unterman TG, et al. The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/ protein kinase B pathway. J Biol Chem 2004; 279:2623-31.
88. Iynedjian PB. Identification of upstream stimulatory factor as transriptional activator of the liver promoter of the glucokinase gene. Biochem J 1998; 333 (Pt 3): 705-12.
89. Lannoy VJ, Decaux JF, Pierreux CT, et al. Liver glucokinase gene expression is controlled by the onecut transcription factor hepatocyte nuclear factor-6. Diabetologia 2002; 45:1136-41.
90. Kim SY, Kim HI, Park SK, et al. Liver glucokinase can be activated by peroxisome proliferator-activated receptor-gamma. Diabetes 2004; 53 Suppl 1: S66-70.
91. Cabrera-Valladares G, Matschinsky FM, Wang J, et al. Effect of retinoic acid on glucokinase activity and gene expression in neonatal and adult cultured hepatocytes. Life Sci 2001; 68:2813-24.
92. Laffitte BA, Chao LC, Li J, et al. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci USA 2003; 100:5419-24.